Insmed (INSM) PT Raised to $195 at Truist Securities

August 10, 2026 7:22 AM

Truist Securities analyst Danielle Brill raised the price target on Insmed (NASDAQ: INSM) to $195.00 (from $185.00) while maintaining a Buy rating.

No results found